Recent progress in the development of docetaxel and paclitaxel analogues

Bibliography

• GUÉRITTE-VOEGELEIN F, GUÉNARD D, MANGATAL L et al.: Structure of a synthetic taxol precursor. N-tert-butoxycarbonyl-10-desacetyl-N- debenzoyltaxol. Acta Cryst. (1990) C46:781-784.
   Google Scholar
• WANI MC, TAYLOR HL, WALL ME, COGGON P, MCPHAIL AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. (1971) 93:2325-2327.
   PubMed Web of Science ®Google Scholar
• SCHIFF PB, FANT J, HORWITZ SB: Promotion of microtubules assembly in vitro by taxol. Nature (1979) 277:665-667.
   PubMed Web of Science ®Google Scholar
• NOGALES E, WOLF SG, DOWNING KH: Structure of the αβ tubulin dimer by electron crystallography. Nature (1998) 391:199-203.
   PubMed Web of Science ®Google Scholar
• LÖWE J, DOWNING KH, NOGALES E: Refined structure of αβ tubulin at 3.5Å resolution. J. Mol. Biol. (2001) 313:1045-1057.
   PubMed Web of Science ®Google Scholar
• SNYDER JP, NETTLES JH, CORNETT B, DOWNING KH, NOGALES E: The binding conformation of taxol® in β-tubulin: a model based on electron crystallographic density. Proc. Natl. Acad. Sci. USA (2001) 98:5312-5313.
   PubMed Web of Science ®Google Scholar
• QUEROLLE O, DUBOIS J, THORET S, ROUSSI F, GUÉRITTE F, GUÉNARD D: Synthesis of C2-C3′ N-linked macrocyclic taxoids. Novel docetaxel analogues with high tubulin activity. J. Med. Chem. (2004) 47:5937-5944.
   PubMed Web of Science ®Google Scholar
• GANESH T, GUZA RC, BANE S et al.: The bioactive taxol conformation on β-tubulin: experimental evidence from highly active constrained analogs. Proc. Natl. Acad. Sci. USA (2004) 101:10006-10011.
   PubMed Web of Science ®Google Scholar
• DE WIT: Shifting paradigms in prostate cancer; docetaxel plus low-dose prednisone – finally an effective chemotherapy. Eur. J. Cancer (2005) 41:502-507.
   PubMedGoogle Scholar
• LIN S, OJIMA I: Recent strategies in the development of taxane anticancer drugs. Expert Opin. Ther. Patents (2000) 10:869-889.
   Web of Science ®Google Scholar
• DUBOIS J, GUÉNARD D, GUÉRITTE F: Recent developments in antitumour taxoids. Expert Opin. Ther. Patents (2003) 13:1809-1823.
   Web of Science ®Google Scholar
• CHAUVIERE G, GUENARD D, PICOT V, SENILH V, POTIER P: Analyse structurale et étude biochimique de produits isolés de l’If. Comptes Rendus Acad. Sci. Paris Ser. II (1981) 293:501-503.
   Google Scholar
• SENILH V, BLECHERT S, COLIN M et al.: New analogs of taxol extracts from Taxus baccata. J. Nat. Prod. (1984) 47:131-137.
   Web of Science ®Google Scholar
• TABATA H: Production of paclitaxel and the related taxoids by cell suspension cultures of Taxus species. Curr. Drug Targets (2006) 7:453-461.
   Google Scholar
• DENIS JN, GREENE AE, GUÉNARD D, GUÉRITTE-VOEGELEIN F, MANGATAL L, POTIER P: Highly efficient, practical approach to natural Taxol. J. Am. Chem. Soc. (1988) 110:5917-5919.
   Google Scholar
• COMMERCON A, BOURZAT JD, DIDIER E, LAVELLE F: Practical semi-synthesis and antimitotic activity of docetaxel and side-chain analogues. In: Taxoid Anticancer Agents: Basic Science and Current Status. Georg GI, Chen TT, Ojima I, Vyas DM (Eds). ACS Symposium Series, American Chemical Society. Washington, DC (1995):233-246.
   Google Scholar
• OJIMA I, HABUS I, ZHAO M et al.: New and efficient approaches to the semi-synthesis of taxol and its C-13 side chain analogs by means of β-lactam synthon method. Tetrahedron (1992) 48:6985-7012.
   Web of Science ®Google Scholar
• HOLTON RA, BIEDEGER RJ, BOATMAN PD: Semi-synthesis of taxol and taxotere. In: Science and applications. Suffness M, (Ed.). CRC Press. Boca Raton, FL (1995) 97-121.
   Google Scholar
• MANGATAL L, ADELINE MT, GUÉNARD D, GUÉRITTE-VOEGELEIN F, POTIER P: Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues. Tetrahedron (1989) 45:4177-4190.
   Web of Science ®Google Scholar
• BALOGLU E, KINGSTON DGI: The taxane diterpenoids. J. Nat. Prod. (1999) 62:1448-1472.
   PubMed Web of Science ®Google Scholar
• HOFFMAN A: Taxanes in hazelnut plants: effects of age, cultivar, health, and individual variation. Abstracts of Papers, 224th ACS National Meeting. Boston, MA, US, August 18-22 (2002).
   Google Scholar
• MCCOY M: Lining up to make a cancer drug. Competition to produce bulk paclitaxel is on the rise, but demand for the drug isn’t following. Chem. Eng. News (2004) 82:12-14.
   Google Scholar
• WALKER K, CROTEAU R: Taxol biosynthetic genes. Phytochemistry (2001) 58:1-7.
   PubMed Web of Science ®Google Scholar
• JENNEWEIN S, WILDUNG MR, CHAU M, WALKER K, CROTEAU R: Random sequencing of an induced Taxus cell cDNA library for identification of clones involved in Taxol biosynthesis. Proc. Natl. Acad. Sci. USA (2004) 101:9149-9754.
   Google Scholar
• JENNEWEIN S, LONG RM, WILLIAMS RM, CROTEAU R: Cytochrome P450 taxadiene 5α-hydroxylase, a mechanistically unusual monooxygenase catalyzing the first oxygenation step of taxol biosynthesis. Chem. Biol. (2004) 11:379-387.
   PubMedGoogle Scholar
• GUÉNARD D, GUÉRITTE-VOEGELEIN F, POTIER P: Taxol and taxotere: discovery, chemistry and structure–activity relationships. Acc. Chem. Res. (1993) 26:160-167.
   Web of Science ®Google Scholar
• KINGSTON DGI, JAGTAP PJ, YUAN H, SAMALA L: The chemistry of taxol and related taxoids. In: Progress in the chemistry of organic natural products. Hertz W, Kirby GW, Moore RE, Steglich W, Tamm C. (Eds). Springer-Verlag, Wien & New York (2002) 84:53-225.
   Google Scholar
• HOLTON RA, ZHANG Z, CLARKE PA, NADIZADEH H, PROCTER DJ: Selective protection of the C(7) and C(10) hydroxyl groups in 10-deacetyl baccatin III. Tetrahedron Lett. (1998) 39:2883-2886.
   Web of Science ®Google Scholar
• DENIS JN, FKYERAT A, GIMBERT Y et al.: Docetaxel (taxotere) derivatives: novel NbCl3-based stereoselective approach to 2′-methyldocetaxel. J. Chem. Soc. Perkin Trans. I (1995) 18811-1815.
   Google Scholar
• KANT J, SCHWATRZ WS, FAIRCHILD C et al.: Diastereoselective addition of Grignard reagents to azetidine-2,3-dione: synthesis of novel taxol analogues. Tetrahedron Lett. (1996) 37:6495-6498.
   Google Scholar
• MASTALERZ H, COOK D, FAIRCHILD CR et al.: The discovery of BMS-275183: an orally efficacious novel taxane. Bioorg. Med. Chem. (2003) 11:4315-4323.
   PubMed Web of Science ®Google Scholar
• GANESH T, NORRIS A, SHARMA S et al.: Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-taxol bioactive conformation. Bioorg. Med. Chem. (2006) 14:3447-3454.
   PubMed Web of Science ®Google Scholar
• SINGER JW, SHAFFER S, BAKER B et al.: Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane. Anticancer Drugs (2005) 16:243-254.
   PubMed Web of Science ®Google Scholar
• BRADLEY MO, WEBB NL, ANTHONY FH et al.: Tumour targeting by covalent conjugation of a natural fatty acid to paclitaxel.Clin. Cancer Res. (2001) 7:3229-3238.
   Google Scholar
• HENNENFENT KL, GOVINDAN R: Novel formulations of taxanes: a review. Old wine in a new bottle? Ann. Oncol. (2006) 17:735-749.
   Google Scholar
• OJIMA I, SLATER JC, MICHAUD E et al.: Syntheses and structure–activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J. Med. Chem. (1996) 39:3889-3896.
   PubMed Web of Science ®Google Scholar
• JARACZ S, CHEN J, KUZNETSOVA V, OJIMA I: Recent advances in tumor-targeting anticancer drug conjugates. Bioorg. Biomed. Chem. (2005) 13:5043-5054.
   PubMed Web of Science ®Google Scholar
• MILLER ML, ROLLER EE, ZHAO RY et al.: Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery. J. Med. Chem. (2004) 47:4802-4805.
   PubMedGoogle Scholar
• ASPLAND SE, BALLATORE C, CASTILLO R et al.: Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells. Bioorg. Biomed. Chem. Lett. (2006) 16:5194-5198.
   PubMed Web of Science ®Google Scholar
• DRIN G, ROUSELLE C, SCHERMANN JM, REES AR, TEMSAMANI J: Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors. AAPS PharmSci. (2002) 4:E26.
   Google Scholar
• OHTSU H, NAKANISHI Y, BASTOW KF, LEE FY, LEE KH: Antitumor agents 216. Synthesis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents. Bioorg. Biomed. Chem. (2003) 11:1851-1857.
   PubMed Web of Science ®Google Scholar
• BARALDI PG, TABRIZI MA, ROMAGNOLI R et al.: Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]- pyrimidine ligands, new tools to characterize A3 adenosine receptors in tumor cell lines. Curr. Med. Chem. (2005) 12:1319-1329.
   PubMedGoogle Scholar
• MERIGHI S, MIRANDOLA P, VARANI K et al.: Pyrazolotriazolo- pyrimidine derivatives sensitize melanom cells to the chemotherapeutic drugs: taxol and vindesine. Biochem. Pharmacol. (2003) 66:739-748.
   PubMedGoogle Scholar
• CIARDELLO F, CAPUTO R, DAMIANO V et al.: Antitumor effect of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Clin. Cancer Res. (2003) 9:1546-1556.
   PubMedGoogle Scholar
• WEDGE SR, KENDREW J, HENNEQUIN LF et al.: AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res. (2005) 65:4389-4400.
   PubMed Web of Science ®Google Scholar
• HE W, MYERS MR, SPADA AP et al.: Potent quinoxazoline-based inhibitors of PDGF recptor tyrosine kinase activity. Part 2: the synthesis and biological activities of RPR127963 an orally bioavailable inhibitor. Bioorg. Med. Chem. Lett. (2003) 13:3097-3100.
   PubMed Web of Science ®Google Scholar
• BAGULEY BC: Antivascular therapy of cancer: DMXAA. Lancet Oncol. (2003) 4:141-148.
   PubMed Web of Science ®Google Scholar
• SLIIM BG, SHALAI-ZWAIN S, PRUIJN FB et al.: Marked potentiation of the antitumor activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Cancer Chemother. Pharmacol. (2003) 51:43-52.
   PubMedGoogle Scholar
• PENNATI M, CAMPBELL AJ, CURTO M et al.: Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol. Cancer Ther. (2005) 4:1328-1337.
   PubMed Web of Science ®Google Scholar
• GUZI T: CYC-202 Cyclacel. Curr. Opin. Invest. Drugs (2004) 5:1311-1318.
   PubMedGoogle Scholar
• PUI CH, JEHA S: Clofarabine. Nat. Rev. Drug Discov. (2005) (Suppl.):S12-S13.
   Google Scholar
• HU L, HOFMANN J, HOLASH J: Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Clin. Cancer Res. (2005) 11:6966-6971.
   PubMed Web of Science ®Google Scholar
• AGRAWAL N, BETTEGOWADA C, CHEONG I et al.: Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc. Natl. Acad. Sci. USA (2004) 101:15172-15177.
   PubMed Web of Science ®Google Scholar
• DANG LH, BETTEGOWDA C, AGRAWAL N et al.: Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol. Ther. (2004) 3:326-337.
   PubMed Web of Science ®Google Scholar
• ROSE WC, WILD R: Therapeutic synergy of oral taxane BMS-275183 and cetuximab versus human tumor xenografts. Clin. Cancer Res. (2004) 10:7413-7417.
   PubMed Web of Science ®Google Scholar
• MARTIN M, PIENKOWSKI T, MACKEY J et al.: Adjuvant docetaxel for node-positive breast cancer. N. Engl. J. Med. (2005) 352:2302-2313.
   PubMed Web of Science ®Google Scholar
• TRUDEAU M, CHARBONNEAU F, GELMON K et al.: Selection of adjuvant therapy for treatment of node-positive breast cancer. Lancet Oncol. (2005) 6:886-898.
   PubMed Web of Science ®Google Scholar
• BRANDES LJ, QUEEN GM, LABELLA FS: N,N-diethyl-2-[4-(phenyl- methyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs. Cancer Chemother. Pharmacol. (2000) 45:298-304.
   PubMed Web of Science ®Google Scholar
• VILLALONA-CALERO MA, ECKHARDT SG, WEISS G et al.: A Phase I and pharmacokinetic study of ecteinascidin-743 on a daily x5 schedule in patients with solid malignancies. Clin. Cancer Res. (2002) 8:75-85.
   PubMed Web of Science ®Google Scholar
• LAPIDUS RG, DANG W, ROSEN DM et al.: Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation. Prostate (2004) 58:291-298.
   PubMed Web of Science ®Google Scholar
• DEJONG JM, LIU Y, BOLLON AP et al.: Genetic engineering of taxol biosynthetic genes in Saccaromyces cerevisiae. Biotechnol. Bioeng. (2006) 93:212-224.
   PubMed Web of Science ®Google Scholar
• ATTARD G, GREYSTOKE A, KAYE S, DE BONO J: Update on tubulin-binding agents. Pathologie Biologie (2006) 54:72-84.
   PubMedGoogle Scholar
• KLAR U, GRAF H, SHENK O, ROHR B, SCHULZ H: New synthetic inhibitors of microtubule depolymerization. Bioorg. Med. Chem. Lett. (1998) 8:1397-1402.
   PubMed Web of Science ®Google Scholar
• FUJI K, WATANABE Y, OHTSUBO T et al.: Synthesis of extremely simplified compounds possessing the key pharmacophore units of Taxol, phenylisoserine and oxetane moieties. Chem. Pharm. Bull. (1999) 47:1334-1337.
   PubMedGoogle Scholar
• GENTILE G, FATTORI D, BOTTA M et al.: Synthesis of dimeric and tetrameric macrolactams with cytotoxic activity. Can. J. Chem. (2000) 78:925-934.
   Google Scholar
• HOWARTH J, KENNY P, MCDONNELL S, O’CONNOR A: The design and synthesis of guanosine compounds with in vitro activity against the colon cancer cell line SW480: non-taxane derived mimics of taxol? Bioorg. Med. Chem. Lett. (2003) 13:2693-2697.
   Google Scholar
• GENG X, GENEY R, PERA P, BERNACKI RJ, OJIMA I: Design and synthesis of de novo cytotoxic alkaloids through mimicking taxoid skeleton. Bioorg. Med. Chem. Lett. (2004) 14:3491-3494.
   PubMed Web of Science ®Google Scholar
• ALMQVIST F, MANNER S, THORNQVIST V et al.: Spirobicyclo[2.2.2]octane derivatives: mimetics of baccatin III and paclitaxel (taxol). Org. Biomol. Chem. (2004) 2:3085-3090.
   PubMedGoogle Scholar
• ROUSSI F, NGO QA, THORET S, GUÉRITTE F, GUÉNARD D: The design and synthesis of new steroidal compounds as potential mimics of taxoids. Eur. J. Org. Chem. (2005) 3952-3961.
   Google Scholar
• GRADISHAR WJ: Albumin-bound paclitaxel: a next generation taxane. Expert Opin. Pharmacother. (2006) 7:1041-1053.
   PubMed Web of Science ®Google Scholar